Back to search

Switzerland· 67129001

Procysbi 25 mg, gélules gastro-résistantes

A mercaptamine product containing mercaptaminum, registered in Switzerland by Chiesi SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A16AA04

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedProcysbi 25 mg, gélules gastro-résist…ATCA16AA04REGISTER NO.67129001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Mercaptamine is registered in 14 of 19 countries.

Countries holding a registration under ATC A16AA04 (mercaptamine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Mercaptamine · ATC A16AA04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mercaptamine costs, country by country.

Normalised to the WHO defined daily dose (2 g), so markets compare like for like.

  • Switzerland: $589.95 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Mercaptamine · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$589.95
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
mercaptaminum
Manufacturer
Chiesi SA
Country
Switzerland (CH)
ATC code
A16AA04
ATC class
Mercaptamine
Defined daily dose
2 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680671290011
    Fl 60 Stk
    CHF 374.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mercaptamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mercaptamine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Cystadrops, Cystagon
  • Liechtenstein · Cystadrops, Cystagon
  • Norway · Cystadrops, Cystagon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c776f4d2-14c4-4d7a-b645-94045211cd71
GET /v1/drugs/c776f4d2-14c4-4d7a-b645-94045211cd71?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "mercaptaminum 25 mg",
  "valid_from": "2024-07-01",
  "limitations": "[{\"description\":\"Die Anwendung von PROCYSBI hat gemäss den Angaben der von Swissmedic genehmigten Fachinformation zu erfolgen:<br>\\nDie Einleitung der PROCYSBI-Therapie sollte unter der Kontrolle eines Arztes erfolgen, der über Erfahrung in der Behandlung von Cystinose verfügt.<br>\\nDie Mercaptamin-Therapie muss umgehend nach Bestätigung der Diagnose einer nephropathischen Cystinose (d.h. anhand eines erhöhten leukozytären Cystingehaltes) eingeleitet werden, damit ein höchstmöglicher therapeutischer Nutzen erreicht wird.<br>\\nNach Kostengutsprache durch den Krankenversicherer bzw. durch die IV-Stelle nach vorgängiger Konsultation des RAD.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2024-07-01\",\"validTo\":\"2027-06-30\"}]",
  "galenic_form": "Kaps 25 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2024-07-01",
  "self_retention_pct": 10
}

See everything about mercaptamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.